For instance, epigallocatechin-3-gallate (EGCG), a major catechin found in green tea, has been reported to suppress prostate cancer progression by inhibiting androgen receptor signaling, which is a crucial pathway targeted in androgen deprivation therapy (ADT) commonly used in prostate cancer treatment [87,229]. This evidence concerns the gene AR and prostate carcinoma.